A carregar...

Daclizumab induction therapy in liver transplant recipients with renal insufficiency

BACKGROUND: The role of interleukin 2 (IL-2) receptor antibodies to avoid the nephrotoxic effects of calcineurin inhibitors in the early post-liver transplant (LT) period is not well defined. AIM: To examine the use of daclizumab induction in LT recipients with renal insufficiency. METHODS: Between...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Asrani, S. K., Kim, W. R., Pedersen, R. A., Charlton, M. R., Kremers, W. K., Therneau, T. M., Rosen, C. B., Dean, P. G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3606263/
https://ncbi.nlm.nih.gov/pubmed/20659283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2010.04408.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!